Progenics Pharmaceuticals
(PGNX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Sales | 3,238 | 5,317 | 3,878 | 3,189 | 3,889 |
| Gross Profit | 3,238 | 5,317 | 3,878 | 3,189 | 3,889 |
| Operating Expenses | 17,790 | 30,365 | 18,216 | 15,607 | 17,171 |
| Operating Income | -14,552 | -25,048 | -14,338 | -12,418 | -13,282 |
| Interest Expense | 235 | 762 | 930 | 1,006 | 2,162 |
| Other Income | 0 | 0 | 0 | 0 | 1,107 |
| Pre-tax Income | -14,787 | -25,810 | -15,268 | -13,424 | -14,337 |
| Income Tax | -83 | -1,453 | -96 | N/A | N/A |
| Net Income Continuous | -14,704 | -24,357 | -15,172 | -13,424 | -2,665 |
| Net Income | $-14,704 | $-24,357 | $-15,172 | $-13,424 | $-2,665 |
| EPS Basic Total Ops | -0.18 | -0.30 | -0.20 | -0.19 | -0.04 |
| EPS Basic Continuous Ops | -0.18 | -0.30 | -0.21 | -0.19 | -0.04 |
| EPS Diluted Total Ops | -0.18 | -0.30 | -0.20 | -0.19 | -0.04 |
| EPS Diluted Continuous Ops | -0.18 | -0.30 | -0.21 | -0.19 | -0.04 |
| EPS Diluted Before Non-Recurring Items | -0.17 | -0.09 | -0.20 | N/A | N/A |
| EBITDA(a) | $9,131 | $-24,624 | $-14,034 | $-12,132 | $-12,993 |